Asco Association

“During the reporting year, the board of directors delegated authority to act on its behalf to the executive committee of the board of directors,consistent with the association's bylaws. Pursuant to the bylaws, the voting members of the executive committee are the chair, treasurer, and one or more voting members of the board of directors. The ceo is a non-voting member of the executive committee. All executive committee members are members of the association's board of directors. The scope of the executive committee's authority is established by the association's executive committee charter, which was approved by the association's board of directors. The charter provides that, except to the extent specifically prohibited by the bylaws, resolution of the board of directors, or applicable law, the executive committee is empowered to make and implement major decisions between board meetings and it may act on items requiring action prior to the next announced board meeting. All actions of the executive committee are reported to the board of directors at the next meeting of the board of directors.”

“Dr. Clifford Hudis, Linda Jensen, and Melissa Tai were all employed by the Association's affiliate, the American Society of Clinical Oncology, the Society, a section 501(c)(3) public charity. Dr. Hudis is the Chief Executive Officer of the Society and Ms. Jensen is the Chief Financial Officer and Executive Vice President of the Society. Dr. Monica Bertagnolli, Dr. Jacob Verweij, Dr. Eric Small, Dr. Peter Adamson, Dr. Howard Burris, III, Dr. Melissa Dillmon, Dr. Laurie Gaspar, Dr. Maha H.A. Hussain, Dr. Reshma Jagsi, Dr. Michael Kosty, Dr. Lori Pierce, Dr. Blase Polite, and Dr. Everett Vokes all served as voting members of the Society's Board of Directors during the tax year. In addition, during the tax year, Dr. Bertagnolli served as Chair of the Board and Past President of the Society, Dr. Burris served as President and Chair of the Board of the Society, Dr. Pierce served as President-Elect and President of the Society, Dr. Vokes served as President-Elect of the Society, and Dr. Gaspar served as Treasurer of the Society.”

“No asco members have the right to receive a share of the organization's profits or excess dues or a share of the organization's net assets upon the organization's dissolution. The categories of asco membership with voting rights and specified rights are as follows: full members. Full members are (a) experienced licensed physicians of any nation who devote a majority of their professional activity to cancer patient care and/or research or education in the biology, diagnosis, prevention or treatment of human cancer (in exceptional cases, other physicians who have made significant contributions to the field are eligible for full member status), and (b) other health professionals at the doctoral level (e.g.,epidemiologists, biostatisticians, public health specialists, nurses, other scientists, etc.) or individuals with equivalent academic ranks who devote a majority of their professional activity to cancer patient care and/or research or education in the biology, diagnosis,prevention or treatment of human cancer. Rights of full members include the right to attend meetings of the members of the association; serve as voting members of committees of the association; hold office in the association; and vote on matters brought to the membership for vote.”

“All asco members are members of both the association and its affiliate, the american society of clinical oncology (the society). Voting members of asco elect all members of the society board of directors. The members of the society board of directors who are in the final year of their terms, and the society's elected officers, who are all elected by the asco voting members, serve as ex-officio voting members of the association board of directors. The categories of asco members who are eligible to vote for the election of members of the governing body of the society are: full members, emeritus members who were full members at the time of request for emeritus member status, and honorary members.”

“Full members have the right to vote on changing the purpose of the association (as set forth in the bylaws), voluntary dissolution of the association, and any such matters that the board of directors brings to the membership for vote.”

“A DRAFT ELECTRONIC COPY OF THE ASSOCIATION's FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS. In addition, before filing, the form was reviewed by the CFO and Chief Legal Officer.”

“The association maintains a number of written conflict of interest policies and standards regarding the disclosure and management of conflicts of interest. These policies and standards cover all association members and employees, directors, officers, committee members, and any person in a relationship with these individuals involving the sharing of income or assets (e.g. Spouse, dependent children). Covered individuals are asked to disclose financial interests in or other relationships with entities that have relevant commercial interests, including employment or leadership positions, consultant or advisory roles, stock ownership, honoraria, research funding, and service as an expert witness. Officers, directors and key employees are also required to disclose service as an officer, director, or trustee of any other professional or advocacy organization relating to science or health care. Completion of a disclosure form is required at the initiation of service and updated annually thereafter or when any material changes occur. The association's conflict of interest policies are intended to help guide the management of actual, potential, and perceived conflicts of interest through disclosure of financial interests or other relationships. Where the nature and extent of a financial relationship suggest disclosure is not adequate to manage a real or potential conflict, covered individuals are required to recuse themselves from decision making. Recusal may be self-selected, or may be requested by the committee chair, officer, or executive-level staff members. In addition, if the association were to contemplate entering into a transaction or arrangement that might benefit the private interest of any interested person (i.e. A board member, director, principal officer, or key employee who has a direct or indirect financial interest in the transaction), it must follow a specific procedure to manage the conflict, including considering alterative transactions that would not give rise to a conflict of interest.”

“Compensation of the ceo is determined by the related organization employing the ceo.”

“The association uses a compensation consultant, which based on responsibilities and comparability data, provides reasonableness assurance for the compensation of the vice president of member services. This review was last conducted in 2018.”

“ASCO Association's governing documents are available on the Virginia State Corporation Commission website. ASCO Association's conflict of interest policy is available on the ASCO website. ASCO Association's financial statements are not available. ASCO Association's Forms 1024 and 990 are available upon request.”

“(2) maintaining the highest standards of oncology medical care through programs supporting education, research, and quality improvement; and (3) increasing awareness among the medical community, patients, and the public of challenges faced by oncology medical professionals that may affect quality of cancer care.”

“The Association's advocacy activities include tracking, analyzing, and influencing pending legislation and regulations and advocating for policies that increase access to high quality cancer care for all patients, and educating its membership, affiliated state and regional oncology societies, and the general public about existing and emerging policies and their impact on cancer research, patients, and providers.”

“from the member magazine, as well as opportunities to create groups.”

“Accreditation & Certification: The Association conducts an accreditation program that furthers the common business interests of its members by maintaining and improving the quality of medical care available to the public and maintaining high standards of excellence in oncology. The Quality Oncology Practice Initiative (QOPI) Certification Program ("QCP") provides a three-year certification recognizing high-quality care for outpatient hematology-oncology practices. The QCP Standards were adapted from the Chemotherapy Administration Safety Standards codeveloped by ASCO and the Oncology Nursing Society and are intended to reduce the risk of errors when providing chemotherapy to patients with cancer. Participating practices receive site visits from experienced oncology professionals to assess compliance with QCP Standards through interviews, observation, and medical record reviews. Participants receive reports documenting their level of compliance with each certification standard and making recommendations or requirements for improved care. QCP Certification is not required for any professional licensing, nor is it required of the Association's members. State/Regional Affiliate Program: The 48 state/regional affiliates interact with the Association and its affiliate, the American Society of Clinical Oncology (Society) through the State Affiliate Council, where each state affiliate has a voting representative charged with serving as the bridge between that state affiliate and the Association and the Society. State affiliates have access to a number of programs, including state society membership recruitment and retention assistance, leadership training, federal-level advocacy support, education and resources on practice-related issues, and a website development tool.”

“Transfer of Assets from the Society: $(11,391,000) QOPI Certification Program Transfer: 148,385 Total: $(11,242,615)”

“Description:bank fees total fees:338636”

“Description:other professional services total fees:760222”

“Description:shared services - labor total fees:738774”